Detalles de la búsqueda
1.
Evaluating the use of pharmacological stress agents during single-photon emission computed tomography myocardial perfusion imaging tests after inadequate exercise stress test.
J Nucl Cardiol
; 29(4): 1788-1795, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33709333
2.
Factors that impact a patient's experience when undergoing single-photon emission computed tomography myocardial perfusion imaging (SPECT-MPI) in the US: A survey of patients, imaging center staff, and physicians.
J Nucl Cardiol
; 28(4): 1507-1518, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31468380
3.
Efficacy and Safety of Mirabegron versus Placebo Add-On Therapy in Men with Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Randomized, Phase 4 Study (PLUS).
J Urol
; 203(6): 1163-1171, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31895002
4.
Overactive bladder in an integrated delivery system: a longitudinal cohort study.
BMC Health Serv Res
; 20(1): 447, 2020 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-32434511
5.
6.
Assessment of women's treatment preferences for vasomotor symptoms due to menopause.
Expert Rev Pharmacoecon Outcomes Res
; 23(10): 1117-1128, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37650213
7.
Handling Missing Data in Health Economics and Outcomes Research (HEOR): A Systematic Review and Practical Recommendations.
Pharmacoeconomics
; 41(12): 1589-1601, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37490207
8.
Evaluating and understanding combination therapy decision drivers for the treatment of overactive bladder in the United States.
J Int Med Res
; 50(5): 3000605221098176, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35588263
9.
Clinical experience with regadenoson SPECT myocardial perfusion imaging: insights into patient characteristics, safety, and impact of results on clinical management.
Int J Cardiovasc Imaging
; 38(1): 257-267, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34387801
10.
Persistence with mirabegron or antimuscarinic treatment for overactive bladder syndrome: Findings from the PERSPECTIVE registry study.
Low Urin Tract Symptoms
; 13(4): 425-434, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-33987973
11.
Mirabegron Vs Placebo Add-on Therapy in Men With Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Safety Analysis From the Randomized, Phase 4 PLUS Study.
Urology
; 147: 235-242, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33045287
12.
Safety and Tolerability Results from the PILLAR Study: A Phase IV, Double-Blind, Randomized, Placebo-Controlled Study of Mirabegron in Patients ≥ 65 years with Overactive Bladder-Wet.
Drugs Aging
; 37(9): 665-676, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32725584
13.
Efficacy, safety, and tolerability of mirabegron in patients aged ≥65yr with overactive bladder wet: a phase IV, double-blind, randomised, placebo-controlled study (PILLAR).
Eur Urol
; 77(2): 211-220, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31733990
14.
Comparative Safety and Efficacy of Treatments for Overactive Bladder Among Older Adults: A Network Meta-analysis.
Drugs Aging
; 37(11): 801-816, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32960422
15.
A Novel, Dose-Adjusted Tacrolimus Trough-Concentration Model for Predicting and Estimating Variance After Kidney Transplantation.
Drugs R D
; 19(2): 201-212, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31073875
16.
Use of Initial Noninvasive Cardiac Testing and Association with Downstream Healthcare Resource: A Retrospective Review of Resources Used Across a 12-Month Window for Probable Type I Myocardial Infarction Patients.
Pharmacoecon Open
; 3(4): 527-535, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31102147
17.
Factors Associated with Improvements in Patient-Reported Outcomes During Mirabegron or Antimuscarinic Treatment of Overactive Bladder Syndrome: A Registry Study (PERSPECTIVE).
Adv Ther
; 36(8): 1906-1921, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31222714
18.
A Prospective, non-intErventional Registry Study of PatiEnts initiating a Course of drug Therapy for overactIVE bladder (PERSPECTIVE): Rationale, design, and methodology.
Contemp Clin Trials
; 70: 83-87, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29777865
19.
Attributes of nuclear imaging centers impacting physician referrals for single-photon emission computed tomography myocardial perfusion imaging tests.
J Med Econ
; 20(8): 777-785, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28406042
20.
The OptiMARK clinical development program: summary of safety data.
J Magn Reson Imaging
; 15(4): 446-55, 2002 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-11948834
Resultados
1 -
20
de 20
1
Próxima >
>>